We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Portable Support System Combines Respiratory Therapies

By HospiMedica International staff writers
Posted on 25 Apr 2017
An innovative respiratory system integrates ventilation, oxygen concentration, cough assistance, suction, and nebulization into one simple, mobile device.

The Ventec Life Systems Ventilation, Oxygen, Cough, Suction, and Nebulization (VOCSN) system is designed to improve care for patients with neuromuscular diseases (such as muscular dystrophies and ALS), impaired lung function (such as COPD, cystic fibrosis, lung cancers, and emphysema), spinal cord injury, and pediatric development complications across the continuum of care, from children five kg and up to adults. More...
Patients can get all five therapies, or just the mix of therapies needed.

The device, which is more than 70% lighter and smaller than current machines, features a nine-hour on-board battery, and is controlled through an intuitive touchscreen interface and user-friendly operating system. Caregivers can seamlessly switch between therapies using the Ventec One-Circuit function with the touch of a button, and no longer need to change circuits between therapies. Instead of having several cumbersome tubes connecting to separate devices, Ventec One-Circuit creates one easy-to-manage system.

“I’ve seen firsthand how improved ventilator technology can enhance the quality of life for patients and caregivers. Our team didn’t want to create just another ventilator, we spent the past five years focused on building a truly integrated solution,” said Doug DeVries, founder and CEO of Ventec. “VOCSN is inspired by ideas from patients, caregivers, medical professionals, and a team of more than 30 leading engineers. New technology was developed to provide best-in-class treatment in a smaller, more energy efficient system.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.